https://www.taxtmi.com/circulars?id=7362 De-licensing removes industrial licensing and public-sector reservation for Vitamin B1, Vitamin B2, Tetracycline, Oxytetracycline and Folic Acid, while products made by re-combinant DNA technology, in vivo nucleic acid active principles, and specific cell- or tissue-targeted formulations remain under compulsory licensing. Entrepreneurs must file an Industrial Entrepreneurs' Memorandum with the Secretariat for Industrial Assistance; LOI holders need only file Part B of the IEM at commencement of commercial production but may file an initial IEM if variations to LOI or licence conditions are contemplated. en-us Fri, 26 Feb 1999 00:00:00 +0530 Fri, 04 Sep 2009 13:51:00 +0530 TaxTMI RSS Generator https://www.taxtmi.com/circulars?id=7362 De-licensing removes industrial licensing and public-sector reservation for Vitamin B1, Vitamin B2, Tetracycline, Oxytetracycline and Folic Acid, while products made by re-combinant DNA technology, in vivo nucleic acid active principles, and specific cell- or tissue-targeted formulations remain under compulsory licensing. Entrepreneurs must file an Industrial Entrepreneurs' Memorandum with the Secretariat for Industrial Assistance; LOI holders need only file Part B of the IEM at commencement of commercial production but may file an initial IEM if variations to LOI or licence conditions are contemplated. Circulars FEMA Fri, 26 Feb 1999 00:00:00 +0530 https://www.taxtmi.com/circulars?id=7362